Bevacizumab for treating HHT patients with severe hepatic involvement or refractory anemia

PLoS One. Authors: Carolina Vázquez, María Laura Gonzalez, Augusto Ferraris, Juan Carlos Bandi, and Marcelo Martín Serra.

This article is available for public use and does not require purchase.